Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
Compare Profit and Loss Results of Medico Remedies
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
150.00
133.00
17.00
12.78%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
150.00
133.00
17.00
12.78%
Expenditure (Ex Depriciation)
Stock Adjustments
-5.00
3.00
-8.00
-266.67%
Raw Materials Consumed
113.00
112.00
1.00
0.89%
Power & Fuel Cost
2.00
5.00
-3.00
-60.00%
Employee Cost
6.00
4.00
2.00
50.00%
Operating Expenses
7.00
3.00
4.00
133.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
1.00
5.00
500.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
138.00
-3.00
-2.17%
Operating Profit (PBDIT) excl Other Income
15.00
-4.00
19.00
475.00%
Other Income
2.00
5.00
-3.00
-60.00%
Operating Profit (PBDIT)
17.00
0.00
17.00
0%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
16.00
0.00
16.00
0%
Depreciation
3.00
2.00
1.00
50.00%
Profit Before Taxation & Exceptional Items
13.00
-1.00
14.00
1,400.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
-1.00
14.00
1,400.00%
Provision for Tax
3.00
0.00
3.00
0%
Profit After Tax
10.00
-2.00
12.00
600.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
32.00
52.00
-20.00
-38.46%
Profit Available for appropriations
42.00
49.00
-7.00
-14.29%
Appropriations
42.00
49.00
-7.00
-14.29%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.22
-0.5
1.72
344.00%
Profit And Loss - Net Sales
Net Sales 150.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.15% vs 3.19% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.22% vs 34.19% in Mar 2024
Profit And Loss - Interest
Interest 1.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.68% vs 10.23% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 10.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 21.74% vs 14.49% in Mar 2024
